Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GiCAEC: Caffeic Acid for Advanced ESCC
NCT04648917Phase 3Unknown
- Sponsor
- First Affiliated Hospital of Henan University of Science and Technology
- Start
- May 2019
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of caffeic acid in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by First Affiliated Hospital of Henan University of Science and Technology. Status: unknown.
02
Drugs
caffeic acid
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT04648917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04648917.